Intensive Care Unit Strain and Mortality for Critically Ill Patients With COVID-19 | Critical Care Medicine | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Intensive Care Unit Strain and Mortality Risk Among Critically Ill Patients With COVID-19—There Is No “Me” in COVID

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Article Information

Published: January 19, 2021. doi:10.1001/jamanetworkopen.2020.35041

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Rubinson L. JAMA Network Open.

Corresponding Author: Lewis Rubinson, MD, PhD, Morristown Medical Center, Atlantic Health System, 100 Madison Ave, Box 20, Morristown, NJ 07960 (lewis.rubinson@atlantichealth.org).

Conflict of Interest Disclosures: Dr Rubinson reported serving on the advisory board for and owning nominal equity in Ventec Life Systems outside the submitted work.

References
1.
Bravata  DM , Perkins  AJ , Myers  LJ ,  et al.  Association of intensive care unit patient load and demand with mortality rates in US Department of Veterans Affairs hospitals during the COVID-19 pandemic.   JAMA Netw Open. 2021;4(1):e2034266. doi:10.1001/jamanetworkopen.2020.34266Google Scholar
2.
Kenyon  C .  Flattening-the-curve associated with reduced COVID-19 case fatality rates — an ecological analysis of 65 countries.   J Infect. 2020;81(1):e98-e99. doi:10.1016/j.jinf.2020.04.007 PubMedGoogle ScholarCrossref
3.
Horby  P , Lim  WS , Emberson  JR ,  et al; RECOVERY Collaborative Group.  Dexamethasone in hospitalized patients with Covid-19 — preliminary report.   N Engl J Med. 2020;NEJMoa2021436. Published online July 17, 2020. doi:10.1056/NEJMoa2021436PubMedGoogle Scholar
4.
US Food and Drug Administration.  Veklury (Remdesivir) EUA Letter of Approval. Reissued October 22, 2020. Accessed December 11, 2020. https://www.fda.gov/media/137564/download
5.
Fiolet  T , Guihur  A , Rebeaud  ME , Mulot  M , Peiffer-Smadja  N , Mahamat-Saleh  Y .  Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors’ response.   Clin Microbiol Infect. 2020;27(1):138-140. doi:10.1016/j.cmi.2020.10.002 PubMedGoogle ScholarCrossref
6.
National Institutes of Health.  Antithrombotic therapy in patients with COVID-19. Updated December 17, 2020. Accessed December 13, 2020. https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/antithrombotic-therapy/
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close